Nikita Shah
Executive Vice President · Amneal Pharmaceuticals, Inc.
- 2025
- Aug 13, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nikita Shah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
- John Kiely - $882K in AMRX purchases and sales in the last 12 months
- Ted C. Nark - $586K in AMRX purchases and sales in the last 12 months
- Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nikita Shah?
Nikita Shah is a corporate insider, tracked as Executive Vice President of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nikita Shah submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Nikita Shah been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($6.42M) across all tracked filings.
